Mal-Exatecan
Mal-Exatecan is a Mal (Maleimide) modified Exatecan , a DNA topoisomerase I (topoisomerase I) inhibitor[1].
Product Specifications
CAS Number
3028213-52-4
UNSPSC
12352203
Target
ADC Payload; Topoisomerase
Related Pathways
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
99.39
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C=CC1=O)N1CCCCCC(N[C@@H]2C3=C4C(C(N5C4)=CC([C@](O)(C(OC6)=O)CC)=C6C5=O)=NC7=CC(F)=C(C)C(CC2)=C73)=O
Molecular Formula
C34H33FN4O7
Molecular Weight
628.65
References & Citations
[1]Mitsui I, et al. A new water-soluble camptothecin derivative, DX-8951f, exhibits potent antitumor activity against human tumors in vitro and in vivo. Jpn J Cancer Res. 1995 Aug;86 (8) :776-82.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
ADC Related
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A1359-77 200 µL
ALOX12, CT (Platelet-type Lipoxygenase 12, Arachidonate 12-lipoxygenase, 12S-type, 12S-lipoxygenase, 12S-LOX, LOG12)
Sign In for Pricing
View Details GTR15126912 1 Vial
Lentiviral human DDX19B shRNA (UAS) - Lentiviral human DDX19B shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details A00070-Fluoro488 100 µg/Vial
Anti-IGF1 Receptor/Igf1r Antibody Picoband® Fluoro488 Conjugated
Sign In for Pricing
View Details 